Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new revision tag, v3.6.6, appears replacing v3.6.5, reflecting an internal update to the page’s version. No changes to the study content or eligibility details are introduced by this update.SummaryDifference0.0%

- Check21 days agoChange DetectedNew location-related entries were added (e.g., Heilongjiang and Harbin, China) and multiple existing sites were removed, changing the geographic footprint and number of locations listed for the study.SummaryDifference0.9%

- Check35 days agoChange DetectedRevision label changed from v3.6.4 to v3.6.5, indicating a minor update to the page's version. This reflects an internal patch or refresh to the page metadata rather than a modification to the study details.SummaryDifference0.0%

- Check57 days agoChange DetectedCholangiocarcinoma has been removed from the study's listed conditions, affecting the diseases covered by this basket trial. A new Revision: v3.6.4 was added, and some related topics and an older revision reference were removed.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.6.3 has been added, replacing the previous Revision: v3.6.0. This update reflects a newer underlying software version powering the page.SummaryDifference0.0%

- Check92 days agoChange DetectedThe page now indicates the study is no longer recruiting and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study); it also updates the header formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and includes a site revision tag (Revision: v3.6.0).SummaryDifference0.2%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.